Diagnostic Medical Systems S.A.
ALDMS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €46,069 | €44,117 | €35,271 | €36,270 |
| % Growth | 4.4% | 25.1% | -2.8% | – |
| Cost of Goods Sold | €27,677 | €28,104 | €21,437 | €23,076 |
| Gross Profit | €18,392 | €16,013 | €13,834 | €13,885 |
| % Margin | 39.9% | 36.3% | 39.2% | 38.3% |
| R&D Expenses | €0 | €2,178 | €2,102 | €3,259 |
| G&A Expenses | €0 | €0 | €0 | €5,644 |
| SG&A Expenses | €0 | -€2,075 | -€2,043 | €5,644 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €18,738 | €327 | €16,233 | €5,545 |
| Operating Expenses | €18,738 | €430 | €16,292 | €14,448 |
| Operating Income | -€346 | -€2,265 | -€5,875 | -€834 |
| % Margin | -0.8% | -5.1% | -16.7% | -2.3% |
| Other Income/Exp. Net | -€2,265 | -€7,569 | -€764 | -€1,937 |
| Pre-Tax Income | -€2,611 | -€9,834 | -€6,639 | -€2,771 |
| Tax Expense | €205 | €2 | €20 | €178 |
| Net Income | -€2,880 | -€4,946 | -€6,820 | -€3,875 |
| % Margin | -6.3% | -11.2% | -19.3% | -10.7% |
| EPS | -0.16 | -0.56 | -0.42 | -0.24 |
| % Growth | 71.4% | -33.3% | -75% | – |
| EPS Diluted | -0.16 | -0.56 | -0.42 | -0.24 |
| Weighted Avg Shares Out | 18,102 | 17,463 | 16,121 | 16,121 |
| Weighted Avg Shares Out Dil | 18,102 | 17,463 | 16,121 | 16,121 |
| Supplemental Information | – | – | – | – |
| Interest Income | €488 | €11 | €33 | €86 |
| Interest Expense | €2,300 | €456 | €225 | €382 |
| Depreciation & Amortization | €2,900 | €2,296 | €2,137 | €1,933 |
| EBITDA | -€200 | €831 | -€4,277 | -€364 |
| % Margin | -0.4% | 1.9% | -12.1% | -1% |